Growth Metrics

Kestra Medical Technologies (KMTS) Return on Invested Capital (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Return on Invested Capital for 3 consecutive years, with 0.64% as the latest value for Q1 2026.

  • Quarterly Return on Invested Capital fell 98.0% to 0.64% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.64% through Jan 2026, down 98.0% year-over-year, with the annual reading at 2.67% for FY2025, N/A changed from the prior year.
  • Return on Invested Capital for Q1 2026 was 0.64% at Kestra Medical Technologies, up from 0.67% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.35% in Q1 2025, with the low at 6.58% in Q2 2025.
  • Average Return on Invested Capital over 3 years is 1.28%, with a median of 0.57% recorded in 2026.
  • The sharpest move saw Return on Invested Capital tumbled -101bps in 2025, then plummeted -98bps in 2026.
  • Over 3 years, Return on Invested Capital stood at 0.34% in 2024, then plummeted by -294bps to 0.67% in 2025, then grew by 4bps to 0.64% in 2026.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.64%, 0.67%, and 0.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.